Overactive Bladder--Pharmacological Aspects

REFERENCES

• Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standard-isation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78.
   PubMed Web of Science ®Google Scholar
• Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760–6.
   PubMed Web of Science ®Google Scholar
• Andersson K-E, Appell R, Awad S, Chapple C, Drutz H, Fourcroy J, et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A, eds. Incontinence, 2nd International Consultation on Incontinence. UK: Plymbridge Distributors Ltd; 2002: pp. 479–511.
   Google Scholar
• Bumstock G. Purinergic signalling in lower urinary tract. In: Handbook of Experimental Pharmacology, Vol 15 1/I. Purinergic and Pyrimidinergic Signalling I Molecular, Nervous and Urogenitary System Function. Abbracchio MP and Williams M, eds. Berlin, Heidel-berg: Springer-Verlag; 2001. pp. 423–515.
   Google Scholar
• Anders son K-E. Bladder activation: afferent mechan-isms. Urology 2002; 59 (Suppl 1): 43–50
   PubMedGoogle Scholar
• de Groat WC, Yoshimura N. Pharmacology of the Scand J Urol Nephrol Suppl 210 lower urinary tract. Annu Rev Pharmacol Toxicol 2001; 41: 69–721.
   Google Scholar
• Andersson K-E. Treatment of the overactive bladder: possible central nervous system drug targets. Urology 2002; 59 (Suppl 1): 18–24.
   PubMedGoogle Scholar
• de Groat WC, Booth AM and Yoshimura N. Neuro-physiology of micturition and its modification in animal models of human disease. In: Maggi CA, ed. The Autonomic Nervous System. Vol. 6, Chapter 8. Nervous Control of the Urogenital System. London: Harwood Academic Publishers; 1993. p. 227–89.
   Google Scholar
• de Groat WC, Downie JW, Levin RI\4, Long Lin AT, Morrison 11-,B, Nishizawa O, et al. Basic neurophysiol-ogy and neuropharmacology. In: Abrams P, Khoury S, Wein A, eds. Incontinence, 1st International Consulta-tion on Incontinence. UK: Plymbridge Distributors Ltd; 1999. p. 105–54.
   Google Scholar
• Bumstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 1999; 194 (3): 335–42.
   PubMedGoogle Scholar
• Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydro-static pressure changes-a possible sensory mechan-ism? J Physiol 1997; 505 (2): 503–11.
   Google Scholar
• Birder LA, Apodaca G, De Groat WC, Kanai AJ. Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 1998; 275 (2 Pt 2): F226–9.
   Google Scholar
• Vlaskovska M, Kasakov L, Rong W, Bodin P, Bardini M, Cockayne DA, et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21: 5670–7.
   PubMed Web of Science ®Google Scholar
• Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Bumstock G, Wood JN. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 1995; 377 (6548): 428–31.
   PubMed Web of Science ®Google Scholar
• Dunn PM, Zhong Y, Burnstock G. P2X receptors in peripheral neurons. Prog Neurobiol 2001; 65: 107–34.
   PubMed Web of Science ®Google Scholar
• Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000; 407 (6807): 1011–5.
   PubMed Web of Science ®Google Scholar
• Elneil S, Skepper JN, Kidd EJ, Williamson JG, Ferguson DR. Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology 2001; 63: 120–8.
   Google Scholar
• Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 2001; 87: 774–9.
   PubMed Web of Science ®Google Scholar
• Namasivayam S, Eardley I, Morrison JF. Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. BJU Int 1999; 84: 854–60.
   Google Scholar
• Pandita RK, Andersson K-E. Intravesical ATP stimu-lates the micturition reflex in awake rats. J Urol 2001; 165 (Suppl): 41 (abstract 169).
   Google Scholar
• Pandita RK, Andersson K-E. Intravesical ATP stimu-lates the micturition reflex in awake, freely moving rats. J Urol 2002; (in press).
   Google Scholar
• Andersson K-E, Persson K. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. . Scand J Urol Nephrol Suppl 1995; 175: 43–53.
   Google Scholar
• Mumtaz FH, Khan MA, Thompson CS, Morgan RJ, Mikhailidis DP. Nitric oxide in the lower urinary tract: physiological and pathological implications. BJU Int 2000; 85: 567–78.
   Google Scholar
• Smet PJ, Edyvane KA, Jonavicius J, Marshall VR. Distribution of NADPH-diaphorase-positive nerves supplying the human urinary bladder. J Auton Nerv Syst 1994; 47: 109–13.
   PubMedGoogle Scholar
• Mohammed H, Santer R M. Distribution and changes with age of nitric oxide synthase-immunoreactive nerves of the rat urinary bladder, ureter and in lumbosacral sensory neurons. Eur J Morphol 2001; 39: 137–44.
   PubMedGoogle Scholar
• De Ridder D, Roskams T, Van Poppel H, Baert L. Nitric oxide synthase expression in neurogenic bladder disease: a pilot study. Acta Neurol Belg 1999; 99: 57–60.
   PubMed Web of Science ®Google Scholar
• Persson K, Poljakovic M, Johansson K, Larsson B. Morphological and biochemical investigation of nitric oxide synthase and related enzymes in the rat and pig urothelium. J Histochem Cytochem 1999; 47: 739–50.
   PubMed Web of Science ®Google Scholar
• Pinna C, Eberini I, Puglisi L, Bumstock G. Presence of constitutive endothelial nitric oxide synthase immuno-reactivity in urothelial cells of hamster proximal urethra. Eur J Pharmacol 1999; 367: 85–9.
   PubMed Web of Science ®Google Scholar
• Fathian-Sabet B, Bloch W, Klotz T, Niggemann S, Jacobs G, Addicks K, et al. Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol 2001; 165: 1724–9.
   Google Scholar
• Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396–401.
   PubMed Web of Science ®Google Scholar
• Pandita RK, Mizusawa H, Andersson KE. Intravesical oxyhemoglobin initiates bladder overactivity in con-scious, normal rats. J Urol 2000; 164: 545–50.
   Google Scholar
• Ozawa H, Chancellor MB, Jung SY, Yokoyama T, Fraser MO, Yu Y, et al. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 1999; 162: 2211–6.
   PubMed Web of Science ®Google Scholar
• Khan MA, Thompson CS, Mumtaz FH, Jeremy JY, Morgan RJ, Mikhailidis DP. Role of prostaglandins in the urinary bladder: an update. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 415–22.
   PubMed Web of Science ®Google Scholar
• Andersson KE. Treatment of overactive bladder: other drug mechanisms. Urology 2000; 55 (5A Suppl): 51–7.
   Google Scholar
• Gilmore NJ, Vane JR. Hormones released into the circulation when the urinary bladder of the anaesthe-tized dog is distended. Clin Sci 1971; 41: 69–83.
   PubMed Web of Science ®Google Scholar
• Breyer RI\4, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001; 41: 661–90.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Watanabe Y, Onoe H, Watanabe Y. Prostacyclin receptor in the brain and central terminals of the primary sensory neurons: an autoradiographic study using a stable prostacyclin analogue [3H]iloprost. Neuroscience 1995; 65: 493–503.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Inadome A, Miyamae K, Iwashita H, Otani M, Masunaga K, et al. Role of prostaglandin E2 in overactive bladder in the spinal cord injury. J Urol 2002; 167: 275 (abstract 1082).
   Google Scholar
• Ishizuka O, Mattiasson A, Andersson KE. Prostaglan-din E2-induced bladder hyperactivity in normal, con-scious rats: involvement of tachykinins? J Urol 1995; 153: 2034–8.
   Google Scholar
• Lecci A, Maggi CA. Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 2001; 101 (1-3): 1–18.
   PubMedGoogle Scholar
• Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH. Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder. J Urol 2000; 163: 331–7.
   PubMed Web of Science ®Google Scholar
• Ishizuka O, Mattiasson A, Andersson KE. Tachykinin effects on bladder activity in conscious normal rats. J Urol 1995; 154: 257–61.
   Google Scholar
• Nakatsuka T, Mena N, Ling J, Gu JG. Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P. Neuroscience 2001; 107: 293–300.
   PubMed Web of Science ®Google Scholar
• Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159–212.
   PubMed Web of Science ®Google Scholar
• Gunthorpe MJ, Benham CD, Randall A, Davis JB. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 2002; 23: 183–91.
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. Impaired nocicep-don and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288 (5464): 306–13.
   Google Scholar
• Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002; 109: 787–98.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Caterina MJ, Nealen ML, Barrick SR, Kiss S, de Groat WC, Birder L. Bladder function in mice lacking the vanilloid receptor 1. J Urol 2002; 167: 34–5 (abstract 138).
   Google Scholar
• Pinna C, Caratozzolo O, Puglisi L. A possible role for urinary bladder epithelium in bradykinin-induced con-traction in diabetic rats. Eur J Pharmacol 1992; 214: 143–8.
   Google Scholar
• Pinna C, Ventura S, Puglisi L, Burnstock G. A pharmacological and histochemical study of hamster urethra and the role of urothelium. Br J Pharmacol 1996; 119: 655–62.
   PubMed Web of Science ®Google Scholar
• Hypolite JA, Longhurst PA, Gong C, Briscoe J, Wein AJ, Levin RM. Metabolic studies on rabbit bladder smooth muscle and mucosa. Mol Cell Biochem 1993; 125: 35–42.
   PubMed Web of Science ®Google Scholar
• Fovaeus M, Fujiwara M, Hogestatt ED, Persson K, Andersson K-E. A non-nitrergic smooth muscle relax-ant factor released from rat urinary bladder by muscarinic receptor stimulation. J Urol 1999; 161: 649–53.
   Google Scholar
• Hawthorn MH, Chapple CR, Cock M, Chess-Williams R. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000; 129: 416–9.
   Google Scholar
• Templeman L, Chapple CR, Chess-Williams R. Uro-thelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol 2002; 167 (2 Pt 1): 742–5.
   Google Scholar
• Warner FJ, Shang F, Millard RJ, Burcher E. Enhance-ment of neurokinin A-induced smooth muscle contrac-tion in human urinary bladder by mucosal removal and phosphoramidon: relationship to peptidase inhibition. Eur J Pharmacol 2002; 438: 171–7.
   PubMed Web of Science ®Google Scholar
• Anderson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev. 1993; 45: 253–308.
   PubMed Web of Science ®Google Scholar
• Yamanishi T, Chapple CR, Chess-Williams R. Which muscarinic receptor is important in the bladder? World J Urol 2001; 19: 299–306.
   Google Scholar
• Hegde SS, Eglen RM. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci 1999; 64: 419–28.
   PubMed Web of Science ®Google Scholar
• Eglen RI\4, Choppin A, Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci. 2001; 22: 409–14.
   PubMedGoogle Scholar
• Harriss DR, Marsh KA, Birmingham AT, Hill SJ. Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 1995; 154: 1241–5.
   PubMed Web of Science ®Google Scholar
• Yamanishi T, Chapple CR, Yasuda K, Chess-Williams R. The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivation. J Urol 2002; 167: 397–401.
   Google Scholar
• Krichevsky VP, Pagala MK, Vaydovsky I, Damer V, Wise GJ. Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction. J Urol 1999; 161: 1644–50.
   Google Scholar
• Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscari-nic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 2000; 97: 9579–84.
   PubMed Web of Science ®Google Scholar
• Somogyi GT, de Groat WC. Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. J Auton Nerv Syst 1992; 37: 89–97.
   PubMedGoogle Scholar
• Tobin G, Sjögren C. Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve trans-mission in the rabbit urinary bladder. J Autonom Nerv Syst 1998; 68: 153–6.
   PubMedGoogle Scholar
• D'Agostino G, Bolognesi ML, Lucchelli A, Vicini D, Balestra B, Spelta V, et al. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol 2000; 129: 493–500.
   PubMed Web of Science ®Google Scholar
• Somogyi GT, de Groat WC. Function, signal transduc-tion mechanisms and plasticity of presynaptic muscari-nic receptors in the urinary bladder. Life Sci 1999; 64: 411–8.
   PubMed Web of Science ®Google Scholar
• Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, et al. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 1997; 120: 1409–18.
   PubMed Web of Science ®Google Scholar
• Braverman AS, Luthin GR, Ruggieri MR. M2 mus-carinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 1998; 275: R1654–60
   Google Scholar
• Braverman A, Legos J, Young W, Luthin G, Ruggieri M. M2 receptors in genito-urinary smooth muscle pathology. Life Sci 1999; 64: 429–36.
   Google Scholar
• Braverman AS, Karlovsky M, Pontari MA, Ruggieri MR. Ageing and hypertrophy change the muscarinic receptor subtypemediating contraction from M3 to M2. J Urol 2002; 167: 43 (abstract 170).
   Google Scholar
• Andersson K-E, Appell R, Cardozo LD, Chapple C, Drutz HP, Finkbeiner AE, et al. The pharmacological treatment of urinary incontinence. BJU Int 1999; 84: 923–47.
   PubMed Web of Science ®Google Scholar
• Smith PH, Cook JB, Prasad EWM. The effect of ubretid on bladder function after recent complete spinal cord injury. Br J Urol 1974; 46: 187–92.
   Google Scholar
• Wessler I, Kirkpatrick CJ, Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely ex-pressed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77: 59–79.
   Google Scholar
• Yoshida M, Inadome A, Murakami S, Miyamae K, Iwashita H, Otani M, et al. Effects of age and muscle stretching on acetylcholine release in isolated human bladder smooth muscle. J Urol 2002; 167: 40 (abstract 160).
   Google Scholar
• Brading AF. A myogenic basis for the overactive bladder. Urology 1997; 50 (6A Suppl): 5–67.
   Google Scholar
• Andersson KE. Advances in the pharmacological control of the bladder. Exp Physiol. 1999 Jan; 84: 195–213.
   PubMed Web of Science ®Google Scholar
• Sjögren C, Andersson K-E, Husted S, Mattiasson A, Willer-Madsen B. Atropine resistance of the transmu-rally stimulated isolated human bladder. J Urol 1982; 128: 1368–71.
   Google Scholar
• Sibley GN. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 1984; 354: 431–43.
   PubMed Web of Science ®Google Scholar
• Luheshi GN, Zar MA. Presence of non-cholinergic motor transmission in human isolated bladder. J Pharm Pharmacol 1990; 42: 223–4.
   PubMed Web of Science ®Google Scholar
• Ruggieri MR, Whitmore KE, Levin RM. Bladder purinergic receptors. J Urol 1990; 144: 176–81.
   Google Scholar
• Smith DJ, Chapple CR. In vitro response of human bladder smooth muscle in unstable obstructed male bladders: a study of pathophysiologica 1 causes? Neu-rourol Urodyn 1994; 134: 14–15.
   Google Scholar
• Bayliss M, Wu C, Newgreen D, Mundy AR, Fry CH. A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 1999; 162: 1833–9.
   Google Scholar
• Calvert RC, Thompson CS, Khan MA, Mikhailidis DP, Morgan RJ, Burnstock G. Alterations in cholinergic and purinergic signaling in a model of the obstructed bladder. J Urol 2001; 166: 1530–3.
   PubMed Web of Science ®Google Scholar
• O'Reilly BA, Kosaka AH, Knight GF, Chang TK, Ford AP, Rymer JM, et al. P2X receptors and their role in female idiopathic detrusor instability. J Urol 2002; 167: 157–64.
   PubMed Web of Science ®Google Scholar
• Palea S, Artibani W, Ostardo E, Trist DG, Pietra C. Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 1993; 150: 2007–12.
   Google Scholar
• Wammack R, Weihe E, Dienes H-P, Hohenfellner R. Die Neurogene Blase in vitro. Akt Urol 1995; 26: 16–18.
   Google Scholar
• Yoshida M, Homma Y, Inadome A, Yono M, Seshita H, Miyamoto Y, et al. Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 2001; 36: 99–109.
   PubMed Web of Science ®Google Scholar
• Lee HY, Bardini M, Burnstock G. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol. 2000; 163: 2002–7.
   Google Scholar
• O'Reilly BA, Kosaka AH, Chang TK, Ford AP, Popert R, Rymer JM, et al. A quantitative analysis of purinoceptor expression in human fetal and adult bladders. J Urol 2001; 165: 1730–4.
   PubMed Web of Science ®Google Scholar
• Moore KH, Ray FR, Barden JA. Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence. J Neurosci 2001; 21: RC166.
   Google Scholar
• O'Reilly BA, Kosaka AH, Chang TK, Ford AP, Popert R, McMahon SB. A quantitative analysis of purino-ceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int 2001; 87: 617–22.
   PubMed Web of Science ®Google Scholar
• NergArdh A, Boréus LO, Naglo AS. Characterization of the adrenergic beta-receptors in the urinary bladder of man and cat. Acta Pharmacol Toxicol 1977; 40: 14–21.
   PubMedGoogle Scholar
• Larsen, JJ. a- and fl-Adrenoceptors in the detrusor muscle and bladder base of the pig and fl-adrenoceptors in the detrusor of man. Br J Urol 1979; 65: 215–22.
   Google Scholar
• Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y, et al. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 1999; 126: 819–25.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Tamura K, Tsutsumi T, Yamamoto T, Nakamura K, Koibuchi Y, et al. Expression and possible functional role of the beta3-adrenoceptor in human and rat detrusor muscle. J Urol 1999; 161: 680–5.
   PubMed Web of Science ®Google Scholar
• Takeda M, Obara K, Mizusawa T, Tomita Y, Arai K, Tsutsui T, et al. Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharma-cological methods. J Pharmacol Exp Ther 1999; 288: 1367–73.
   PubMed Web of Science ®Google Scholar
• Igawa Y, Yamazaki Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, et al. Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 2001; 165: 240–4.
   PubMed Web of Science ®Google Scholar
• Morita T, Iizuka H, Iwata T, Kondo S. Function and distribution of beta3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter. J Smooth Muscle Res 2000; 36: 21–32.
   PubMedGoogle Scholar
• Tanaka N, Tamai T, Mukaiyama H, Hirabayashi A, Muranaka H, Ishikawa T, et al. m-Adrenoceptor agonists for the treatment of frequent urination and urinary incontinence: 2-14-(2-IR1S,2R)-2-hydroxy-2 - (4-hydroxypheny1)-1-methylethyflaminoIethypphe-noxy1-2-methylpropioni c acid. Biorg Med Chem 2001; 9: 3265–71.
   PubMed Web of Science ®Google Scholar
• Woods M, Carson N, Norton NW, Sheldon JH, Argentieri TM. Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 2001; 166: 1142–7.
   Google Scholar
• Yamanishi T, Chapple CR, Yasuda K, Yoshida K, Chess-Williams R. The role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscle. Br J Pharmacol 2002; 135: 129–34.
   Google Scholar
• Goepel M, Wittmann A, Riibben H, Michel MC. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 1997; 25: 199–206.
   PubMedGoogle Scholar
• Malloy BJ, Price DT, Price RR, Bienstock AM, Dole MK, Funk BL, et al. Alphal-adrenergic receptor subtypes in human detrusor. J Urol 1998; 160: 937–43.
   PubMed Web of Science ®Google Scholar
• Perlberg S, Caine M. Adrenergic response of bladder muscle in prostatic obstruction. Urology 1982; 20: 524–37.
   PubMed Web of Science ®Google Scholar
• Sundin T, Dahlstrom A. The sympathetic innervation of the urinary bladder and urethra in the normal state and after parasympathetic denervation at the spinal root level. An experimental study in cats. Scand J Urol Nephrol 1973; 7: 131–49.
   PubMed Web of Science ®Google Scholar
• Hampel C, Dolber PC, Smith MP, Savic SL, Thuroff JW, Thor KB, et al. Modulation of bladder alpha 1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 2002; 167: 1513–21.
   PubMed Web of Science ®Google Scholar
• Marks LS, Curtis SP, Narayan P. Effects of a highly selective alpha-1A antagonist on urinary flow rate in men with symptomatic BPH. J Urol 2000; 163 (suppl): 308 (abstract 1369).
   Google Scholar
• Blue DR, Grino PB, Jung DT, Harbisom MP, Ford APWD. Evaluation of Ro 70–004, a selective a1A-adrenoceptor antagonist, in men with benign prostatic hyperplasia (BPH). Presented at the 5th International Consultation on BPH (June 25–28, 2000), Paris (abstract).
   Google Scholar
• Yamamoto T, Ghosh R, De Groat WC, Somogyi GT. Facilitation of transmitter release in the urinary bladders of neonatal and adult rats via alphal-adrenoceptors. Eur J Pharmacol 2001; 414: 31–5.
   PubMed Web of Science ®Google Scholar
• Somogyi GT, Chancellor MB, de Groat WC. Analysis of the inhibitory effects of doxazosin on bladder alpha-1 adrenoceptors. J Urol 2002; 167: 41 (abstract 162).
   Google Scholar